Sarepta Therapeutics, Inc. (SRPT)
16.71
+0.48
(+2.96%)
USD |
NASDAQ |
Mar 06, 16:00
17.49
+0.78
(+4.67%)
After-Hours: 20:00
Sarepta Therapeutics SG&A Expense (TTM) : 491.72M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Merck & Co., Inc. | 10.73B |
| REGENXBIO, Inc. | 60.48M |
| Keros Therapeutics, Inc. | 35.11M |
| Alnylam Pharmaceuticals, Inc. | 1.211B |
| PTC Therapeutics, Inc. | 347.14M |